Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease.
López-Bastida, Julio
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. [electronic resource] - Journal of Alzheimer's disease : JAD 2009 - 399-407 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1387-2877
10.3233/JAD-2009-0965 doi
Alzheimer Disease--drug therapy
Cholinesterase Inhibitors--economics
Cost-Benefit Analysis--economics
Disease Progression
Donepezil
Humans
Indans--economics
Markov Chains
Piperidines--economics
Quality of Life
Sensitivity and Specificity
Spain--epidemiology
Treatment Outcome
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. [electronic resource] - Journal of Alzheimer's disease : JAD 2009 - 399-407 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1387-2877
10.3233/JAD-2009-0965 doi
Alzheimer Disease--drug therapy
Cholinesterase Inhibitors--economics
Cost-Benefit Analysis--economics
Disease Progression
Donepezil
Humans
Indans--economics
Markov Chains
Piperidines--economics
Quality of Life
Sensitivity and Specificity
Spain--epidemiology
Treatment Outcome